Affiliation:
1. Chitkara College of Pharmacy, Chitkara University, Punjab,India
Abstract
Background :
Dermatological disorders are cutaneous infirmities
which are frequently occurring and increasing at an alarming rate. These range
from mild itching/redness (dermatitis) to fatal skin cancers and has posed a major
health concern. Azadirachta indica A. Juss (commonly known as neem), a
member of Meliaceae family, is an Indian medicinal plant which has been known
for its health promoting effects since ancient times.
Objective:
The review highlights the traditional practices, pharmacological aspects,
and formulatory approach of neem for the treatment of dermatological disorders.
Further, recent patents and novel delivery systems (developed and in pipeline)
improving skin delivery and therapeutic profile of neem are discussed.
Results :
Neem is a traditional medicinal plant that has been employed for the prevention
and treatment of numerous ailments covering systemic and topical disorders.
Scientific studies have validated the traditional claims of neem and attributed
these health benefits to the presence of more than 300 structurally diverse and
complex compounds. It possesses anti-inflammatory, antibacterial, analgesic, antiviral,
antifungal, immunomodulatory and antioxidant activities which substantiate
its use as skin therapy. Various novel formulations and associated patents that
improved the permeability of neem based products across skin could be found in
literature.
Conclusion :
Critical appraisal of available literature revealed that neem possesses
anti-microbial, anti-inflammatory, antioxidant and antiseptic properties. Thus
it has the potential to be developed as a single effective therapy for the management
of multimodal skin disorders. Further, pharmaceutical tailoring of neem by
implication of novel carriers could enhance its penetrability across skin.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献